Literature DB >> 9579839

Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now?

R T Oliver1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9579839      PMCID： PMC2150173          DOI： 10.1038/bjc.1998.219

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  21 in total

1.  Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration.

Authors:  M G Leahy; D Pitfield; S Popert; C J Gallagher; R T Oliver
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Authors:  S A Rosenberg; M T Lotze; J C Yang; P M Aebersold; W M Linehan; C A Seipp; D E White
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

3.  [Resection of the stomach with grafting of a short antiperistaltic segment from the small intestine].

Authors:  I L Rotkov
Journal:  Eksp Khir Anesteziol       Date:  1966 Mar-Apr

4.  Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

Authors:  C Bain; Y Merrouche; I Puisieux; J Y Blay; S Negrier; V Bonadona; C Lasset; F Lanier; A Duc; L Gebuhrer; T Philip; M C Favrot
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer.

Authors:  D J Hunter; J E Manson; G A Colditz; M J Stampfer; B Rosner; C H Hennekens; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

6.  Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma.

Authors:  R T Oliver; A B Nethersell; J M Bottomley
Journal:  Br J Urol       Date:  1989-02

7.  A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.

Authors:  J K Joffe; R E Banks; M A Forbes; S Hallam; A Jenkins; P M Patel; G D Hall; G Velikova; J Adams; A Crossley; P W Johnson; J T Whicher; P J Selby
Journal:  Br J Urol       Date:  1996-05

8.  Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma.

Authors:  M E Osband; P T Lavin; R K Babayan; S Graham; D L Lamm; B Parker; I Sawczuk; S Ross; R J Krane
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

Review 9.  Tuberculosis and migration. The Mitchell Lecture 1994.

Authors:  P D Davies
Journal:  J R Coll Physicians Lond       Date:  1995 Mar-Apr

10.  Deprivation and survival from breast cancer.

Authors:  C T Schrijvers; J P Mackenbach; J M Lutz; M J Quinn; M P Coleman
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.